MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma
Authors
Keywords
miR-655-3p, Hepatocellular carcinoma, ADAM10, β-catenin pathway, Proliferation, Migration and invasion
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 35, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-04
DOI
10.1186/s13046-016-0368-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma
- (2016) Peihang Jing et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms
- (2015) Laura Novellasdemunt et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma
- (2015) Bo You et al. CANCER SCIENCE
- Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
- (2015) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4
- (2015) Jun-Nian Zhou et al. HEPATOLOGY
- MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors
- (2015) Kuang-Hsiang Chuang et al. HEPATOLOGY
- The Cytoplasmic Domain of A Disintegrin and Metalloproteinase 10 (ADAM10) Regulates Its Constitutive Activity but Is Dispensable for Stimulated ADAM10-dependent Shedding
- (2015) Thorsten Maretzky et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Signaling by exosomal microRNAs in cancer
- (2015) Germana Falcone et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma
- (2015) Chengli Du et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1)
- (2015) Yasuyuki Shitomi et al. MOLECULAR BIOLOGY OF THE CELL
- Norcantharidin modulates miR-655-regulated SENP6 protein translation to suppresses invasion of glioblastoma cells
- (2015) Zhenxing Zhang et al. TUMOR BIOLOGY
- Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas
- (2015) Yu-Chao Chang et al. Oncotarget
- 14q32-encoded microRNAs mediate an oligometastatic phenotype
- (2015) Abhineet Uppal et al. Oncotarget
- ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer
- (2015) Katharina Feldinger et al. Oncotarget
- Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells
- (2014) Yang Kai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Multimodal treatment of hepatocellular carcinoma
- (2014) Dirk Graf et al. European Journal of Internal Medicine
- A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression
- (2014) Wei Zhang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer
- (2014) Sercan Ergün et al. MOLECULAR BIOLOGY REPORTS
- Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression
- (2014) J Zhang et al. ONCOGENE
- Origins of Metastatic Traits
- (2013) Sakari Vanharanta et al. CANCER CELL
- Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma
- (2013) Ming-Qi Fan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma
- (2013) Yuanyuan Wang et al. Journal of Translational Medicine
- MiR-134/487b/655 Cluster Regulates TGF- -Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells
- (2013) K. Kitamura et al. MOLECULAR CANCER THERAPEUTICS
- miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2
- (2013) Yosuke Harazono et al. PLoS One
- MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
- (2012) Silvia Giordano et al. HEPATOLOGY
- EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells
- (2011) Magdalena M. Grabowska et al. CELLULAR SIGNALLING
- miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes
- (2011) Harsh Dweep et al. JOURNAL OF BIOMEDICAL INFORMATICS
- MicroRNA: Biogenesis, Function and Role in Cancer
- (2010) Leigh-Ann MacFarlane et al. CURRENT GENOMICS
- The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres
- (2010) Shailender S Kanwar et al. Molecular Cancer
- Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage
- (2009) Geert van Tetering et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Shedding Light on Proteolytic Cleavage of CD44: The Responsible Sheddase and Functional Significance of Shedding
- (2009) Ivan Stamenkovic et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started